AgMedica Bioscience Inc. granted EU GMP (European Union Good Manufacturing Practices) Certification for cannabis extracts

(Chatham, ON) – Wednesday November 23, 2022 AgMedica Bioscience Inc. has been granted EU GMP certification (European Union Good Manufacturing Practices) for cannabis extracts, produced in its pharma-grade indoor grow facility located in Chatham, Ontario.

EU GMP certification is the highest recognition available to companies in the pharmaceutical space. AgMedica has demonstrated capability in following the guidelines that provide instruction for manufacturing, testing, and quality assurance in order to ensure AgMedica’s product is safe for human consumption. This certification is an essential piece needed to export EU GMP certificated pharmaceutical grade medical cannabis to importers and distributors in international markets that require EU GMP certification, allowing for global expansion.

AgMedica distinguishes itself as one of few fully indoor grow facilities in Canada that have achieved this level of certification. This certification joins the growing list of granted certifications, which include:

– EU GMP Certification for dried flower
– Health Canada certifications to cultivate, process and sell cannabis
– Israel Medical Cannabis Standard (IMC-G.A.P) [CUMCS equivalency] by the Israeli Medical Cannabis Agency (IMCA)